Avalyn director reports 64,919-share stock option
Avalyn Pharma Inc. director Heather D. Turner reported her initial equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Avalyn Pharma Inc. director Heather D. Turner reported her initial equity holdings. The filing shows a stock option giving her the right to buy 64,919 shares of common stock at an exercise price of $5.58 per share, expiring on October 29, 2034.
According to the vesting terms, 1/8 of the shares underlying this option vest in substantially equal quarterly installments on each quarterly anniversary of October 30, 2024, as long as she continues in service. This is a compensation-related option holding, not a buy or sell transaction.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Turner Heather D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 64,919 contracts (Direct)
Footnotes (1)
- F1. 1/8th of the shares underlying this option vest and become exercisable in substantially equal quarterly installments on each quarterly anniversary of October 30, 2024, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Underlying option shares: 64,919 shares
Exercise price: $5.58/share
Shares following transaction: 64,919 shares
+3 more
6 metrics
Underlying option shares
64,919 shares
Common stock underlying stock option holding
Exercise price
$5.58/share
Stock option exercise price
Shares following transaction
64,919 shares
Total underlying shares reported for the option
Option expiration date
October 29, 2034
Final date to exercise the reported option
Vesting fraction
1/8 of shares
Portion of option vesting in quarterly installments
Vesting start reference date
October 30, 2024
Quarterly anniversary date used for vesting schedule
Key Terms
Stock Option (right to buy), underlying security, exercise price, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
underlying security financial
"underlying_security_title: Common Stock"
exercise price financial
"conversion_or_exercise_price: 5.5800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares underlying this option vest and become exercisable in substantially equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2034-10-29T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider position did Heather D. Turner report in Avalyn Pharma (AVLN)?
Heather D. Turner reported holding a stock option on Avalyn Pharma common stock. The option covers 64,919 underlying shares at an exercise price of $5.58, providing equity-based compensation linked to her service as a director on the company’s board.
Is the Avalyn Pharma (AVLN) Form 3 a buy or sell by Heather Turner?
The Avalyn Pharma Form 3 does not report a buy or sell transaction. It discloses Heather Turner’s existing stock option holding as an insider, detailing the number of underlying shares, exercise price, and vesting schedule as part of her compensation package.
What are the key terms of Heather Turner’s Avalyn Pharma (AVLN) stock option?
Her Avalyn Pharma stock option has an exercise price of $5.58 per share and expires on October 29, 2034. It covers 64,919 underlying common shares, subject to a time-based vesting schedule tied to continued service as a director.
How does Heather Turner’s Avalyn Pharma (AVLN) option vest over time?
One-eighth of the option’s underlying shares vest in substantially equal quarterly installments. Vesting occurs on each quarterly anniversary of October 30, 2024, provided Heather Turner continues to serve, gradually increasing the portion of the option that becomes exercisable.
What does the Avalyn Pharma (AVLN) Form 3 reveal about derivative holdings?
The Form 3 shows a derivative holding: a stock option on Avalyn Pharma common stock. It lists 64,919 underlying shares, a $5.58 exercise price, and an October 29, 2034 expiration, indicating a long-dated equity incentive rather than an immediate market transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
